within Pharmacolibrary.Drugs.ATC.A;

model A12CB03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 1.1666666666666666e-05,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A12CB03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Zinc protein complex is a dietary supplement formulation where zinc is chelated with amino acids or proteins. It is used to treat or prevent zinc deficiency, especially in populations at risk such as malnourished children, pregnant women, and the elderly. There is no evidence that zinc protein complex is approved as a stand-alone prescription drug; it is available as a food supplement.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic studies were found for zinc protein complex as identified by ATC code A12CB03. Provided PK parameters are estimated based on general knowledge of oral zinc supplements.</p><h4>References</h4><ol><li><p>Korkmaz-Icöz, S, et al., &amp; Szabó, G (2016). Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway. <i>Cardiovascular diabetology</i> 15 75–None. DOI:<a href=&quot;https://doi.org/10.1186/s12933-016-0383-8&quot;>10.1186/s12933-016-0383-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27153943/&quot;>https://pubmed.ncbi.nlm.nih.gov/27153943</a></p></li><li><p>Yoshikawa, Y, et al., &amp; Sakurai, H (2011). Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes. <i>Chemical &amp; pharmaceutical bulletin</i> 59(8) 972–977. DOI:<a href=&quot;https://doi.org/10.1248/cpb.59.972&quot;>10.1248/cpb.59.972</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21804241/&quot;>https://pubmed.ncbi.nlm.nih.gov/21804241</a></p></li><li><p>Yasuno, T, et al., &amp; Yamamoto, A (2011). The disposition and intestinal absorption of zinc in rats. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 44(3) 410–415. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2011.08.024&quot;>10.1016/j.ejps.2011.08.024</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21907799/&quot;>https://pubmed.ncbi.nlm.nih.gov/21907799</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A12CB03;
